Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Journal of Extracellular Vesicles|June 20, 2023
Tuberous Sclerosis Complex cell-derived EVs have an altered protein cargo capable of regulating their microenvironment and have potential as disease biomarkersMuireann Ní Bhaoighill, Juan M Falcón-Pérez, Félix Royo, et al.
Cancers|October 13, 2018
Energy Stress-Mediated Cytotoxicity in Tuberous Sclerosis Complex 2-Deficient Cells with Nelfinavir and Mefloquine TreatmentHenry D McCann, Charlotte E Johnson, Rachel J Errington, et al.
The Journal of Clinical Endocrinology and Metabolism|October 27, 2015
Reversal of Pathological Features of Graves' Orbitopathy by Activation of Forkhead Transcription Factors, FOXOsL Zhang, Q H Ji, F Ruge, et al.
The Journal of Allergy and Clinical Immunology|September 1, 1993
Airway allergy to trimellitic anhydride in guinea pigs: different time courses of IgG1 titer and airway responses to allergen challengeH Arakawa, J Lötvall, I Kawikova, et al.
Nanoscale|August 15, 2017
A DNA bipedal nanowalker with a piston-like expulsion strokeQ Y Yeo, I Y Loh, S R Tee, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2013
Reactive nitrogen species regulate autophagy through ATM-AMPK-TSC2-mediated suppression of mTORC1Durga N Tripathi, Rajdeep Chowdhury, Laura J Trudel, et al.
The Journal of Clinical Endocrinology and Metabolism|April 25, 2014
Possible targets for nonimmunosuppressive therapy of Graves' orbitopathyL Zhang, F Grennan-Jones, M S Draman, et al.
Nanoscale|May 5, 2018
Inchworm bipedal nanowalkerY H Chiang, S L Tsai, S R Tee, et al.
The Journal of Biological Chemistry|December 22, 2009
mTOR Ser-2481 autophosphorylation monitors mTORC-specific catalytic activity and clarifies rapamycin mechanism of actionGhada A Soliman, Hugo A Acosta-Jaquez, Elaine A Dunlop, et al.
Pageof 9